127 related articles for article (PubMed ID: 11307146)
41. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.
Frühwald MC; O'Dorisio MS; Pietsch T; Reubi JC
Pediatr Res; 1999 May; 45(5 Pt 1):697-708. PubMed ID: 10231868
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
Ueberberg B; Tourne H; Redmann A; Walz MK; Schmid KW; Mann K; Petersenn S
Horm Metab Res; 2005 Dec; 37(12):722-8. PubMed ID: 16372224
[TBL] [Abstract][Full Text] [Related]
43. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
44. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
45. Prognostic marker analysis in pediatric intracranial ependymomas.
McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
[TBL] [Abstract][Full Text] [Related]
46. Brain somatostatin receptors are up-regulated in somatostatin-deficient mice.
Ramírez JL; Mouchantaf R; Kumar U; Otero Corchon V; Rubinstein M; Low MJ; Patel YC
Mol Endocrinol; 2002 Aug; 16(8):1951-63. PubMed ID: 12145348
[TBL] [Abstract][Full Text] [Related]
47. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
[TBL] [Abstract][Full Text] [Related]
48. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
[TBL] [Abstract][Full Text] [Related]
49. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
[TBL] [Abstract][Full Text] [Related]
50. Human ovarian cancers express somatostatin receptors.
Halmos G; Sun B; Schally AV; Hebert F; Nagy A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3509-12. PubMed ID: 11061491
[TBL] [Abstract][Full Text] [Related]
51. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
52. Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors.
Fjällskog ML; Ludvigsen E; Stridsberg M; Oberg K; Eriksson B; Janson ET
Med Oncol; 2003; 20(1):59-67. PubMed ID: 12665686
[TBL] [Abstract][Full Text] [Related]
53. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1.
Reynaert H; Vaeyens F; Qin H; Hellemans K; Chatterjee N; Winand D; Quartier E; Schuit F; Urbain D; Kumar U; Patel YC; Geerts A
Gastroenterology; 2001 Oct; 121(4):915-30. PubMed ID: 11606505
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.
de Bruin C; Pereira AM; Feelders RA; Romijn JA; Roelfsema F; Sprij-Mooij DM; van Aken MO; van der Lelij AJ; de Herder WW; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2009 Apr; 94(4):1118-24. PubMed ID: 19141584
[TBL] [Abstract][Full Text] [Related]
55. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
56. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
[TBL] [Abstract][Full Text] [Related]
57. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
58. Somatostatin receptor manipulation.
Visser-Wisselaar HA; Hofland LJ; van Uffelen CJ; van Koetsveld PM; Lamberts SW
Digestion; 1996; 57 Suppl 1():7-10. PubMed ID: 8813458
[TBL] [Abstract][Full Text] [Related]
59. Growing vascular endothelial cells express somatostatin subtype 2 receptors.
Watson JC; Balster DA; Gebhardt BM; O'Dorisio TM; O'Dorisio MS; Espenan GD; Drouant GJ; Woltering EA
Br J Cancer; 2001 Jul; 85(2):266-72. PubMed ID: 11461088
[TBL] [Abstract][Full Text] [Related]
60. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]